Everpar Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Sell
12,152
-144
-1% -$33.6K 0.88% 26
2026
Q1
$3.01M Buy
12,296
+1,002
+9% +$233K 1.04% 18
2025
Q4
$2.34M Sell
11,294
-101
-0.9% -$20K 0.87% 24
2025
Q3
$2.11M Buy
11,395
+729
+7% +$125K 0.84% 22
2025
Q2
$1.63M Buy
10,666
+442
+4% +$67.9K 0.74% 27
2025
Q1
$1.7M Buy
10,224
+930
+10% +$146K 0.9% 20
2024
Q4
$1.34M Sell
9,294
-73
-0.8% -$11.3K 0.68% 30
2024
Q3
$1.52M Buy
9,367
+212
+2% +$33.8K 0.79% 26
2024
Q2
$1.34M Buy
9,155
+1,720
+23% +$256K 0.67% 29
2024
Q1
$1.18M Buy
7,435
+129
+2% +$20.5K 0.72% 26
2023
Q4
$1.15M Buy
+7,306
New +$1.12M 0.53% 39

Other funds holding JNJ

Everpar Advisors's JNJ Position: Q2 2026 in Review

Everpar Advisors reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q2 2026, selling an estimated $33.6K and leaving 12,152 shares worth $3.09M. The position accounts for 0.88% of the portfolio, ranked #26.

Everpar Advisors first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Everpar Advisors held 12,152 shares of Johnson & Johnson worth $3.09M as of Q2 2026.
  • Everpar Advisors sold 144 Johnson & Johnson shares in Q2 2026, an estimated $33.6K.
  • Johnson & Johnson made up 0.88% of Everpar Advisors's portfolio in Q2 2026, its #26 holding.
  • Everpar Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.